• Home
  • Search
  • Oxybutynin for Primary Palmer Hyperhidrosis Attenuates Migraine Attacks and Burdens.
  • Cite Icon2
  • https://doi.org/10.7759/cureus.44826Copy DOI Icon

Oxybutynin for Primary Palmer Hyperhidrosis Attenuates Migraine Attacks and Burdens.

  • Sep 7, 2023
  • Cureus
  • Masahito Katsuki
Show More
  • Abstract
  • Highlights & Summary
  • PDF
  • Literature Map
  • References
  • Citations
  • Similar Papers
Abstract

Migraine is a neurological disorder with recurrent headaches accompanied by burdens in social life. Primary palmar hyperhidrosis is a chronic condition with excessive sweating of the palms that can significantly impair quality of life. Primary hyperhidrosis can cause anxiety, and stress, including anxiety, is the most common inducer of migraine headaches. Recently, oxybutynin has been used for primary palmar hyperhidrosis. We herein describe a 26-year-old female migraine patient with primary palmar hyperhidrosis whose migraine attacks and burdens were attenuated after the prescription of an oxybutynin lotion formula. The patient's monthly headache days (MHD) and monthly acute medication intake days (AMD) at the first visit were 10 and 9. Headache Impact Score 6 (HIT-6) at the initial visit was 63. After the prescription of Japanese herbal kampo medicine Goreisan (TJ-17), Goshuyuto (TJ-31), and 200 mg of valproic acid, MHD, AMD, and HIT-6 decreased gradually. However, these parameters could not improve sufficiently at nine months: MHD 4, AMD 4, and HIT-6 52. We first prescribed a lotion formulation of 20% oxybutynin hydrochloride at nine months. After this, migraine was further attenuated, and stress related to primary palmar hyperhidrosis was reduced; at 12 months, the patient had achieved MHD 2, AMD 2, and HIT-6 48. She will continue receiving primary palmar hyperhidrosis treatment while tapering off migraine prophylaxis. While the exact mechanisms connecting migraine and primary hyperhidrosis remain uncertain, this case raises important questions about the potential interplay between stress, sweating, and migraine triggers.

Loading PDF

Similar Papers
  • Research Article
  • Citations1

The Rate of Compensatory Sweating and Clinical Outcomes of Selective Thoracoscopic Sympathectomy (Ramicotomy) in Patients with Primary Palmar Hyperhidrosis

  • Jan 04, 2021
  • Archives of Neuroscience
  • Karamollah Toolabi +4
  • Research Article

Investigation and analysis of personality characteristics of primary palmar hyperhidrosis patients: a cross-sectional observational study

  • Apr 23, 2025
  • European Journal of Medical Research
  • Xiaoyu Wang +3
  • Research Article
  • Citations122

Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials.

  • Mar 01, 2023
  • Cephalalgia : an international journal of headache
  • Faraidoon Haghdoost +5
  • Research Article
  • Citations1

Effect of T4 endoscopic thoracic sympathicotomy on life quality in patients with primary palmar hyperhidrosis

  • Oct 01, 2015
  • Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
  • Peng Xiao +2
  • Research Article
  • Citations19

Quality of life and social isolation in Greek adolescents with primary focal hyperhidrosis treated with botulinum toxin type A: a case series.

  • Dec 29, 2014
  • Pediatric Dermatology
  • Anargyros Kouris +5
  • Research Article
  • Citations2

A comparison of T3 sympathectomy versus T4 sympathectomy in the treatment of primary palmer hyperhidrosis

  • Sep 05, 2006
  • National Medical Journal of China
  • Yan-Guo Liu +8
  • PDF
  • Research Article
  • Citations28

Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway

  • Aug 12, 2020
  • The Journal of Headache and Pain
  • Amanda Hansson-Hedblom +4
  • Research Article
  • Citations3

Patient Preferences for Episodic Migraine Medications: A Discrete Choice Experiment of Self-Injectable Versus Oral Treatments Targeting Calcitonin Gene-Related Peptide Pathway.

  • Mar 01, 2025
  • Patient preference and adherence
  • Chiara Whichello +5
  • Research Article
  • Citations11

Rates and risk factors for migraine progression using multiple definitions of progression: Results of the longitudinal OVERCOME (US) study.

  • Mar 14, 2025
  • Headache
  • Dawn C Buse +8
  • Research Article

Unilevel (T3) versus Bilevel (T3 – T4) Sympathictomy in the Management of Palmar Hyperhidrosis; Does It Affect the Incidence and Severity of Postoperative Compensatory Sweating?

  • Sep 01, 2024
  • The Medical Journal of Cairo University
  • Mohamed A Abdelhady, M.D.; Mohamed Ahmed F Hussein, M.D.; Heshamel +1
  • Research Article
  • Citations15

Morphometric Analysis of Thoracic Ganglion Neurons in Subjects with and without Primary Palmar Hyperhidrosis

  • Dec 14, 2013
  • Annals of Vascular Surgery
  • Flavio Roberto Garbelini De Oliveira +6
  • PDF
  • Research Article
  • Citations31

Erenumab for Migraine Prevention in a 1-Year Compassionate Use Program: Efficacy, Tolerability, and Differences Between Clinical Phenotypes

  • Dec 10, 2021
  • Frontiers in Neurology
  • Jean Schoenen +5
  • Research Article
  • Citations134

Botulinum toxin type A in primary palmar hyperhidrosis: randomized, single-blind, two-dose study.

  • Dec 01, 2001
  • Neurology
  • Daniela Saadia +3
  • Research Article
  • Citations15

Reduction in migraine-associated burden after eptinezumab treatment in patients with chronic migraine

  • Mar 25, 2022
  • Cephalalgia
  • Peter Mcallister +4
  • PDF
  • Research Article
  • Citations4

Anatomical variations of the thoracic sympathetic ganglions and their effects on sympathicotomy for primary palmar hyperhidrosis

  • Apr 01, 2023
  • Clinical Autonomic Research
  • Guotian Pei +6
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.